Abstract
Background
This study aims to develop an attention-based deep learning model for distinguishing benign from malignant breast lesions on CESM.
Methods
Preoperative CESM images of 1239 patients, which were definitely diagnosed on pathology in a multicentre cohort, were divided into training and validation sets, internal and external test sets. The regions of interest of the breast lesions were outlined manually by a senior radiologist. We adopted three conventional convolutional neural networks (CNNs), namely, DenseNet 121, Xception, and ResNet 50, as the backbone architectures and incorporated the convolutional block attention module (CBAM) into them for classification. The performance of the models was analysed in terms of the receiver operating characteristic (ROC) curve, accuracy, the positive predictive value (PPV), the negative predictive value (NPV), the F1 score, the precision recall curve (PRC), and heat maps. The final models were compared with the diagnostic performance of conventional CNNs, radiomics models, and two radiologists with specialised breast imaging experience.
Results
The best-performing deep learning model, that is, the CBAM-based Xception, achieved an area under the ROC curve (AUC) of 0.970, a sensitivity of 0.848, a specificity of 1.000, and an accuracy of 0.891 on the external test set, which was higher than those of other CNNs, radiomics models, and radiologists. The PRC and the heat maps also indicated the favourable predictive performance of the attention-based CNN model. The diagnostic performance of two radiologists improved with deep learning assistance.
Conclusions
Using an attention-based deep learning model based on CESM images can help to distinguishing benign from malignant breast lesions, and the diagnostic performance of radiologists improved with deep learning assistance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Some or all data, models, or code generated or used during the study are available from the corresponding author by request.
References
DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69:438–51.
Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311:1327–35.
Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen. 2012;19:42–56.
Lee-Felker SA, Tekchandani L, Thomas M, Gupta E, Andrews-Tang D, Roth A, et al. Newly diagnosed breast cancer: comparison of contrast-enhanced spectral mammography and breast MR imaging in the evaluation of extent of disease. Radiology. 2017;285:389–400.
Mao N, Yin P, Li Q, Wang Q, Liu M, Ma H, et al. Radiomics nomogram of contrast-enhanced spectral mammography for prediction of axillary lymph node metastasis in breast cancer: a multicenter study. Eur Radiol. 2020;30:6732–9.
Mao N, Yin P, Wang Q, Liu M, Dong J, Zhang X, et al. Added value of radiomics on mammography for breast cancer diagnosis: a feasibility study. J Am Coll Radiol. 2019;16:485–91.
Mao N, Wang Q, Liu M, Dong J, Xiao C, Sun N, et al. Computerized image analysis to differentiate benign and malignant breast tumors on magnetic resonance diffusion weighted image: a preliminary study. J Comput Assist Tomogr. 2019;43:93–97.
Liu Z, Li Z, Qu J, Zhang R, Zhou X, Li L, et al. Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study. Clin Cancer Res. 2019;25:3538–47.
Li H, Zhu Y, Burnside ES, Drukker K, Hoadley KA, Fan C, et al. MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays. Radiology. 2016;281:382–91.
Patel BK, Ranjbar S, Wu T, Pockaj BA, Li J, Zhang N, et al. Computer-aided diagnosis of contrast-enhanced spectral mammography: a feasibility study. Eur J Radiol. 2018;98:207–13.
Lin F, Wang Z, Zhang K, Yang P, Ma H, Shi Y, et al. Contrast-enhanced spectral mammography-based radiomics nomogram for identifying benign and malignant breast lesions of sub-1 cm. Front Oncol. 2020;10:573630.
Truhn D, Schrading S, Haarburger C, Schneider H, Merhof D, Kuhl C. Radiomic versus convolutional neural networks analysis for classification of contrast-enhancing lesions at multiparametric breast MRI. Radiology. 2019;290:290–7.
Zheng X, Yao Z, Huang Y, Yu Y, Wang Y, Liu Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nat Commun. 2020;11:1236.
Jiang M, Li CL, Luo XM, Chuan ZR, Lv WZ, Li X, et al. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer. Eur J Cancer. 2021;147:95–105.
Perek S, Kiryati N, Zimmerman-Moreno G, Sklair-Levy M, Konen E, Mayer A. Classification of contrast-enhanced spectral mammography (CESM) images. Int J Comput Assist Radiol Surg. 2019;14:249–57.
Song J, Zheng Y, Zakir Ullah M, Wang J, Jiang Y, Xu C, et al. Multiview multimodal network for breast cancer diagnosis in contrast-enhanced spectral mammography images. Int J Comput Assist Radiol Surg. 2021;16:979–88.
Wang H, Wang S, Qin Z, Zhang Y, Li R, Xia Y. Triple attention learning for classification of 14 thoracic diseases using chest radiography. Med Image Anal. 2021;67:101846.
Zhang R, Duan H, Cheng J, Zheng Y. A study on tuberculosis classification in chest X-ray using deep residual attention networks. Annu Int Conf IEEE Eng Med Biol Soc. 2020;2020:1552–5.
Woo S, Park J, Lee J-Y, Kweon IS. CBAM: convolutional block attention module. arXiv:1807.06521v2 [Preprint]. 2018 [cited 2018 Jul 18]: [17 p]. Available from: https://arxiv.org/abs/1807.06521
Chen H, Yang BW, Qian L, Meng YS, Bai XH, Hong XW, et al. Deep learning prediction of ovarian malignancy at US compared with O-RADS and expert assessment. Radiology 2022;304:106–13.
Huang G, Liu Z, Maaten Lvd, Weinberger KQ. Densely connected convolutional networks. arXiv:1608.06993v5 [Preprint]. 2018 [cited 2018 Jan 28]: [9 p]. Available from: https://arxiv.org/abs/1608.06993
Chollet F. Xception: deep learning with depthwise separable convolutions. arXiv:1610.02357v3 [Preprint]. 2018 [cited 2018 Apr 4]: [8 p]. Available from: https://arxiv.org/abs/1610.02357
He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. arXiv:1512.03385v1 [Preprint]. 2015 [cited 2015 Dec 10]: [12 p]. Available from: https://arxiv.org/abs/1512.03385
Russakovsky O, Deng J, Su H, Krause J, Satheesh S, Ma S, et al. ImageNet large scale visual recognition challenge. Int J Comput Vis. 2015;115:211–52.
Jiang Y, Zhang Z, Yuan Q, Wang W, Wang H, Li T, et al. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study. Lancet Digital Health. 2022;4:e340–50.
Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, Batra D. Grad-CAM: visual explanations from deep networks via gradient-based localization. Int J Comput Vis. 2020;128:336–59.
Lee CH, Phillips J, Sung JS, Lewin JM, Newell MS. Contrast enhanced mammography (CEM) (A supplement to ACR BI-RADS® Mammography 2013). American College of Radiology. 2022. https://www.acr.org/-/media/ACR/Files/RADS/BI-RADS/BIRADS_CEM_2022.pdf
Whitney HM, Taylor NS, Drukker K, Edwards AV, Papaioannou J, Schacht D, et al. Additive benefit of radiomics over size alone in the distinction between benign lesions and luminal a cancers on a large clinical breast MRI dataset. Acad Radiol. 2019;26:202–9.
Parekh VS, Jacobs MA. Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI. NPJ Breast Cancer. 2017;3:43.
Bickelhaupt S, Jaeger PF, Laun FB, Lederer W, Daniel H, Kuder TA, et al. Radiomics based on adapted diffusion kurtosis imaging helps to clarify most mammographic findings suspicious for cancer. Radiology. 2018;287:761–70.
Zhang Q, Xiao Y, Suo J, Shi J, Yu J, Guo Y, et al. Sonoelastomics for breast tumor classification: a radiomics approach with clustering-based feature selection on sonoelastography. Ultrasound Med Biol. 2017;43:1058–69.
Qiao M, Li C, Suo S, Cheng F, Hua J, Xue D, et al. Breast DCE-MRI radiomics: a robust computer-aided system based on reproducible BI-RADS features across the influence of datasets bias and segmentation methods. Int J Comput Assist Radiol Surg. 2020;15:921–30.
Zhao S, Zhang X, Zhong H, Qin Y, Li Y, Song B, et al. Background parenchymal enhancement on contrast-enhanced spectral mammography: influence of age, breast density, menstruation status, and menstrual cycle timing. Sci Rep. 2020;10:8608.
Lei C, Wei W, Liu Z, Xiong Q, Yang C, Yang M, et al. Mammography-based radiomic analysis for predicting benign BI-RADS category 4 calcifications. Eur J Radiol. 2019;121:108711.
Wang S, Sun Y, Li R, Mao N, Li Q, Jiang T, et al. Diagnostic performance of perilesional radiomics analysis of contrast-enhanced mammography for the differentiation of benign and malignant breast lesions. Eur Radiol. 2021;32:639–49.
Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts H. Artificial intelligence in radiology. Nat Rev Cancer. 2018;18:500–10.
Becker AS, Marcon M, Ghafoor S, Wurnig MC, Frauenfelder T, Boss A. Deep learning in mammography: diagnostic accuracy of a multipurpose image analysis software in the detection of breast cancer. Invest Radiol. 2017;52:434–40.
Yala A, Lehman C, Schuster T, Portnoi T, Barzilay R. A deep learning mammography-based model for improved breast cancer risk prediction. Radiology. 2019;292:60–6.
Zhang Q, Peng Y, Liu W, Bai J, Zheng J, Yang X, et al. Radiomics based on multimodal MRI for the differential diagnosis of benign and malignant breast lesions. J Magn Reson Imaging. 2020;52:596–607.
Guo X, Liu Z, Sun C, Zhang L, Wang Y, Li Z, et al. Deep learning radiomics of ultrasonography: Identifying the risk of axillary non-sentinel lymph node involvement in primary breast cancer. EBioMedicine. 2020;60:103018.
McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H, et al. International evaluation of an AI system for breast cancer screening. Nature. 2020;577:89–94.
Dalmis MU, Gubern-Merida A, Vreemann S, Bult P, Karssemeijer N, Mann R, et al. Artificial intelligence-based classification of breast lesions imaged with a multiparametric breast MRI protocol with Ultrafast DCE-MRI, T2, and DWI. Invest Radiol. 2019;54:325–32.
Qian X, Pei J, Zheng H, Xie X, Yan L, Zhang H, et al. Prospective assessment of breast cancer risk from multimodal multiview ultrasound images via clinically applicable deep learning. Nat Biomed Eng. 2021;5:522–32.
Xi IL, Zhao Y, Wang R, Chang M, Purkayastha S, Chang K, et al. Deep learning to distinguish benign from malignant renal lesions based on routine MR imaging. Clin Cancer Res. 2020;26:1944–52.
Funding
The study was supported by the National Natural Science Foundation of China (82001775 and 62176140), the Natural Science Foundation of Shandong Province of China (ZR2021MH120 and ZR2022MH274), the Special Fund for Breast Disease Research of Shandong Medical Association (YXH2021ZX055), and Taishan Scholars (tsqn202103197).
Author information
Authors and Affiliations
Contributions
(1) Guarantor of integrity of the entire study: HM and CX. (2) Study concepts and design: all authors. (3) Literature research: all authors. (4) Clinical studies: all authors. (5) Experimental studies/data analysis: all authors. (6) Statistical analysis: HZ. (7) Manuscript preparation: all authors. (8) Manuscript editing: all authors.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
This retrospective multicentre study was approved by the institutional review board of Yantai Yuhuangding Hospital, and the patient informed consent was waived.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mao, N., Zhang, H., Dai, Y. et al. Attention-based deep learning for breast lesions classification on contrast enhanced spectral mammography: a multicentre study. Br J Cancer 128, 793–804 (2023). https://doi.org/10.1038/s41416-022-02092-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-022-02092-y